Join
Live feed
·
PRReleasevia Quantisnow
DURECT Corporation logo

DURECT and Innocoll Announce a $136 Million U.S. Licensing Agreement for POSIMIR® (Bupivacaine Solution)

ByQuantisnow·Wall Street's wire, on your screen.
DRRX· DURECT Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DRRX (DURECT Corporation) and more on Quantisnow.